Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jul 06, 2016 $3.31 $3.49 $3.20 $3.39 257 900
Jul 05, 2016 $3.36 $3.45 $3.32 $3.34 99 400
Jul 01, 2016 $3.37 $3.49 $3.32 $3.45 186 900
Jun 30, 2016 $3.69 $3.69 $3.37 $3.44 177 400
Jun 29, 2016 $3.32 $3.67 $3.32 $3.58 452 400
Jun 28, 2016 $3.28 $3.33 $3.20 $3.33 205 100
Jun 27, 2016 $3.32 $3.47 $3.21 $3.25 191 300
Jun 24, 2016 $3.35 $3.45 $3.35 $3.38 401 500
Jun 23, 2016 $4.00 $4.10 $3.45 $3.50 2 828 900
Jun 22, 2016 $3.57 $3.57 $3.37 $3.45 156 600
Jun 21, 2016 $3.48 $3.54 $3.41 $3.54 199 300
Jun 20, 2016 $3.60 $3.72 $3.48 $3.54 290 000
Jun 17, 2016 $3.80 $3.84 $3.57 $3.64 389 000
Jun 16, 2016 $3.70 $3.80 $3.33 $3.68 731 649
Jun 15, 2016 $3.82 $4.58 $3.70 $3.82 6 870 197
Jun 14, 2016 $3.34 $3.40 $3.24 $3.30 202 672
Jun 13, 2016 $3.44 $3.44 $3.16 $3.26 190 425
Jun 10, 2016 $3.35 $3.48 $3.26 $3.29 347 526
Jun 09, 2016 $3.40 $4.26 $3.31 $3.44 3 652 421
Jun 08, 2016 $3.32 $3.45 $3.20 $3.41 411 640
Jun 07, 2016 $3.60 $3.63 $3.15 $3.38 696 521
Jun 06, 2016 $3.62 $3.84 $3.45 $3.63 829 439
Jun 03, 2016 $3.70 $4.14 $3.51 $3.64 1 556 565
Jun 02, 2016 $3.35 $4.50 $3.11 $3.89 8 108 561
Jun 01, 2016 $3.25 $3.29 $3.02 $3.15 505 081
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT